ADIPOQ and type 2 diabetes mellitus: In type 2 diabetes mellitus and metabolic syndrome, pro-inflammatory cytokines linked to insulin resistance and low-grade chronic inflammation are elevated, while the anti-inflammatory molecule adiponectin is decreased [33].